Suppr超能文献

老年患者焦虑症的最佳管理

Optimal management of anxiety in older patients.

作者信息

Weiss K J

机构信息

Delaware Valley Research Associates Inc., King of Prussia, Pennsylvania, USA.

出版信息

Drugs Aging. 1996 Sep;9(3):191-201. doi: 10.2165/00002512-199609030-00005.

Abstract

Although the incidence of anxiety disorders diminishes with age, the prevalence of anxiety symptoms among older patients is substantial. These symptoms, which include cognitive and somatic manifestations, are a source of diminished quality of life. The many potential sources of illness- and medication-induced anxiety must be excluded before instituting treatment. The general principles of antianxiety medication treatment in older patients include: (i) symptom relief with minimum sedation; (ii) improvement in sleep; (iii) freedom from autonomic and cognitive toxicities; and (iv) freedom from physical dependence and drug interactions. Older compounds such as the tricyclic antidepressants should be avoided, since more modern agents (e.g. benzodiazepines and buspirone) are well tolerated and effective. Modern antidepressants have also been used to reduce anxiety symptoms, although there is a potential for the opposite effect to occur. The selective serotonin reuptake inhibitors appear to be better suited to treating syndromes such as panic and obsessive-compulsive disorder, whereas nefazodone would be a better choice for generalised anxiety complicated by depression.

摘要

尽管焦虑症的发病率会随着年龄增长而降低,但老年患者中焦虑症状的患病率却相当高。这些症状包括认知和躯体表现,是生活质量下降的一个原因。在开始治疗之前,必须排除许多由疾病和药物引起焦虑的潜在因素。老年患者抗焦虑药物治疗的一般原则包括:(i)以最小的镇静作用缓解症状;(ii)改善睡眠;(iii)无自主神经和认知毒性;(iv)无身体依赖性和药物相互作用。应避免使用如三环类抗抑郁药等较老的化合物,因为更现代的药物(如苯二氮䓬类药物和丁螺环酮)耐受性良好且有效。现代抗抑郁药也已被用于减轻焦虑症状,尽管可能会出现相反的效果。选择性5-羟色胺再摄取抑制剂似乎更适合治疗恐慌和强迫症等综合征,而奈法唑酮对于伴有抑郁症的广泛性焦虑症是更好的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验